Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework.
Saved in:
| Title: | Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework. |
|---|---|
| Authors: | Shemesh CS; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Chan P; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Marchand M; Certara Strategic Consulting, Paris, France., Gonçalves A; Certara Strategic Consulting, Paris, France., Vadhavkar S; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Wu B; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Li C; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Jin JY; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Hack SP; Product Development Oncology, Genentech Inc., South San Francisco, California, USA., Bruno R; Clinical Pharmacology, Genentech-Roche, Marseille, France. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Sep; Vol. 114 (3), pp. 644-651. Date of Electronic Publication: 2023 Jun 02. |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
